Fig. 1
From: Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Immunoreactivity after SARS-CoV-2 BNT162b2 mRNA vaccine in HD-patients. a IgG-antibody response to Covid-19 spike protein (Log10 anti-S). The cut-off for positive results was set to 100 AU/mL (Abbott Units/milliliter) and 50 AU/mL for negative results (quantitative method). Values between 50 and 100 AU/mL were considered borderline. b T-cell reactivity to Covid-19 spike protein (Log10). The cut off of the ELISPOT assay was set to 7 SFU/well (units). c IgG-antibody response to Covid-19 nucleocapsid antigen (anti-N). The cut-off for the qualitative method for anti-N was 1.4 S/CO (Signal to Cut-off Value). Values between 0.9 and 1.39 were consider borderline